These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 32189151)
1. Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [ Lau J; Pan J; Rousseau E; Uribe CF; Seelam SR; Sutherland BW; Perrin DM; Lin KS; Bénard F EJNMMI Res; 2020 Mar; 10(1):25. PubMed ID: 32189151 [TBL] [Abstract][Full Text] [Related]
2. Microscale radiosynthesis, preclinical imaging and dosimetry study of [ Lisova K; Sergeev M; Evans-Axelsson S; Stuparu AD; Beykan S; Collins J; Jones J; Lassmann M; Herrmann K; Perrin D; Lee JT; Slavik R; van Dam RM Nucl Med Biol; 2018 Jun; 61():36-44. PubMed ID: 29747035 [TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging. Liu Z; Pourghiasian M; Bénard F; Pan J; Lin KS; Perrin DM J Nucl Med; 2014 Sep; 55(9):1499-505. PubMed ID: 24970911 [TBL] [Abstract][Full Text] [Related]
4. Automated synthesis, preclinical toxicity, and radiation dosimetry of [ Toyohara J; Sakata M; Tago T; Colabufo NA; Luurtsema G EJNMMI Res; 2020 Jul; 10(1):84. PubMed ID: 32700099 [TBL] [Abstract][Full Text] [Related]
5. (18)F-trifluoroborate derivatives of [des-arg(10)]kallidin for imaging bradykinin b1 receptor expression with positron emission tomography. Liu Z; Amouroux G; Zhang Z; Pan J; Hundal-Jabal N; Colpo N; Lau J; Perrin DM; Bénard F; Lin KS Mol Pharm; 2015 Mar; 12(3):974-82. PubMed ID: 25629412 [TBL] [Abstract][Full Text] [Related]
7. Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging. Lau J; Liu Z; Lin KS; Pan J; Zhang Z; Vullo D; Supuran CT; Perrin DM; Bénard F J Nucl Med; 2015 Sep; 56(9):1434-40. PubMed ID: 26205302 [TBL] [Abstract][Full Text] [Related]
8. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo. Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142 [TBL] [Abstract][Full Text] [Related]
9. Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog Zhang J; Wang H; Jacobson O; Cheng Y; Niu G; Li F; Bai C; Zhu Z; Chen X J Nucl Med; 2018 Nov; 59(11):1699-1705. PubMed ID: 29653971 [TBL] [Abstract][Full Text] [Related]
10. Development of [ Otaru S; Paulus A; Imlimthan S; Kuurne I; Virtanen H; Liljenbäck H; Tolvanen T; Auchynnikava T; Roivainen A; Helariutta K; Sarparanta M; Airaksinen AJ Bioconjug Chem; 2022 Jul; 33(7):1393-1404. PubMed ID: 35709482 [TBL] [Abstract][Full Text] [Related]
11. (18)F-AmBF3-MJ9: a novel radiofluorinated bombesin derivative for prostate cancer imaging. Pourghiasian M; Liu Z; Pan J; Zhang Z; Colpo N; Lin KS; Perrin DM; Bénard F Bioorg Med Chem; 2015 Apr; 23(7):1500-6. PubMed ID: 25757604 [TBL] [Abstract][Full Text] [Related]
12. Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate. Ma MT; Cullinane C; Waldeck K; Roselt P; Hicks RJ; Blower PJ EJNMMI Res; 2015 Dec; 5(1):52. PubMed ID: 26452495 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of an Nunes PSG; Zhang Z; Kuo HT; Zhang C; Rousseau J; Rousseau E; Lau J; Kwon D; Carvalho I; Bénard F; Lin KS J Labelled Comp Radiopharm; 2018 Apr; 61(4):370-379. PubMed ID: 29247455 [TBL] [Abstract][Full Text] [Related]
14. Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging. Persson M; El Ali HH; Binderup T; Pfeifer A; Madsen J; Rasmussen P; Kjaer A Nucl Med Biol; 2014 Mar; 41(3):290-5. PubMed ID: 24533988 [TBL] [Abstract][Full Text] [Related]
15. Erratum: Automated synthesis and dosimetry of 6-deoxy-6-[(18)F]fluoro-D-fructose (6-[(18)F]FDF): a radiotracer for imaging of GLUT5 in breast cancer. Bouvet V; Jans HS; Wuest M; Soueidan OM; Grant T; Mercer J; McEwan AJ; West FG; Cheeseman CI; Wuest F Am J Nucl Med Mol Imaging; 2015; 5(1):95. PubMed ID: 25625031 [TBL] [Abstract][Full Text] [Related]
16. Super-selective hepatic arterial infusions as established technique ('ARETAIEION' Protocol) of [177Lu]DOTA-TATE in inoperable neuroendocrine liver metastases of gastro-entero-pancreatic (GEP) tumors. Limouris GS; Karfis I; Chatzioannou A; Paphiti MI; Lyra M; Gennatas K; Nikou G; Voros D; Pragulidis GP; Polydorou AA; Gouliamos A Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):551-8. PubMed ID: 23358409 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization? Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541 [TBL] [Abstract][Full Text] [Related]
20. Automated synthesis and dosimetry of 6-deoxy-6-[(18)F]fluoro-D-fructose (6-[(18)F]FDF): a radiotracer for imaging of GLUT5 in breast cancer. Bouvet V; Jans HS; Wuest M; Soueidan OM; Mercer J; McEwan AJ; West FG; Cheeseman CI; Wuest F Am J Nucl Med Mol Imaging; 2014; 4(3):248-59. PubMed ID: 24795839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]